CJC-1295 — What South Africans Should Know
This page is for educational purposes only. It does not provide medical advice, dosing guidance, prescriptions or treatment recommendations.
⚠️ Important: CJC-1295 may be a regulated medicine, scheduled substance or unregistered research compound in South Africa. Always consult a qualified healthcare professional before researching, purchasing or using any peptide or research compound. Full disclaimer →
What is CJC-1295 commonly searched for?
CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH). It is a modified version of the naturally occurring GHRH peptide, engineered to extend its half-life. It is a research compound and is not a registered medicine for general public use.
Why do people research CJC-1295?
CJC-1295 is commonly researched in the context of growth hormone stimulation, body composition, fat loss and anti-ageing research. It is frequently paired with Ipamorelin in online discussions. It attracts interest from people researching performance, recovery and body composition.
This information describes what people research — not a claim that CJC-1295 achieves these outcomes. PeptideIQ SA does not make therapeutic claims about any compound.
Safety and Regulatory Questions
🇿🇦 SAHPRA / South Africa
CJC-1295 is not registered with SAHPRA as a medicine in South Africa. Injectable forms supplied through non-licensed channels would not comply with South African medicines legislation.
SAHPRA is the South African Health Products Regulatory Authority. They regulate medicines, medical devices and scheduled substances. sahpra.org.za →
🏅 WADA / Anti-Doping
Growth Hormone Releasing Hormone (GHRH) and its analogues are listed on the WADA Prohibited List. If you compete in sport, CJC-1295 would be considered a prohibited substance and use could result in a positive anti-doping test.
Always verify current status at the official source. WADA Prohibited List → | Global DRO →
🚩 Red Flags When Buying CJC-1295 Online
- ✕ Injectable CJC-1295 offered without a prescription or pharmacy involvement
- ✕ No WADA prohibited status disclosed to competitive athletes
- ✕ No cold-chain shipping for a temperature-sensitive compound
- ✕ No Certificate of Analysis (COA)
- ✕ Sellers making body composition or anti-ageing treatment claims
- ✕ WhatsApp-only or unverified business operations
If a seller does not address these points proactively, treat it as a significant risk signal.
Questions to Ask a Qualified Professional
Before making any decisions about CJC-1295, bring these questions to a qualified healthcare professional:
Is CJC-1295 classified as a GHRH analogue and therefore prohibited under WADA?
Is this compound a scheduled substance under SAHPRA in South Africa?
What human clinical trial evidence exists for CJC-1295?
What are the known risks of injectable growth hormone-related compounds?
What is the difference between research-grade and pharmaceutical-grade compounds?
What legal alternatives support recovery and performance without prohibited substances?
More resources from PeptideIQ SA
Use our free calculator, read the safety checklist, or submit an enquiry for professional routing — before making any decisions.
Related Compound Education
Full disclaimer: The information on this page is for general educational purposes only. It does not constitute medical advice, a prescription, dosing guidance, a recommendation to use any specific compound, or a clinical opinion. PeptideIQ SA is not a medical service and does not provide peptide protocols, injection guidance, or supply regulated medicines. CJC-1295 may be a regulated medicine, scheduled substance, or unregistered research compound in South Africa. Its legal status may differ by formulation and use. Always consult a qualified healthcare professional and verify regulatory status with SAHPRA before making any decisions. Full Medical Disclaimer →